AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, ...
Home-based oncology transforms practice transformation with clear bagging, protecting Medicare reimbursement, provider ...
UChicago Medicine’s Obada Shamaa, MD, PhD, discusses why bronchiectasis is underrecognized and how to personalize airway ...
PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know ...
Kidney Week 2026 brought strong IgAN data, looked back on 5 years of value-based kidney care, and highlighted evidence of ...
Meta-analysis suggests off-label upadacitinib drives major alopecia areata hair regrowth and SALT score gains, but phase 3 ...
Participating insurers reduced prior authorization requirements by 11% overall, equating to approximately 6.5 million fewer requests, with Medicare Advantage experiencing a greater than 15% reduction.
October's FDA approvals brought notable advances beyond oncology, adding new treatment options in allergy and immunology, ...
A clinical-note analysis of more than 1000 patients found rising off-label BPC-157 use for pain and healing, with outcomes ...
A gradient boosting model identified MASLD in lean adults with an AUC of 0.779, using 8 routine clinical measurements.
Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and ...
Pharmacists are moving beyond order verification into patient education, adverse effect mitigation, and parts of toxicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results